CClinicalTrials.gg
CompletedNCT07034612Updated Jun 27, 2025

Choroidal Changes During Cardiopulmonary Bypass

An observational study in Diabetic Retinopathy (DR), Cardiopulmonary Bypass and Retinal Vascular Diseases, sponsored by Samsun University. Completed at 1 site in Turkey (Türkiye). Open to participants aged 30 Years to 70 Years. Per ClinicalTrials.gov, last updated 2025-06-27.

Sponsored by Samsun University · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
102
Ages
30 Years to 70 Years
Sex
All
01

Study summary

This prospective observational study investigates the impact of pulsatile versus non-pulsatile cardiopulmonary bypass (CPB) flow on choroidal circulation in diabetic and non-diabetic patients undergoing elective coronary artery bypass grafting (CABG). A total of 104 patients aged 30 to 70 years will be included, with balanced distribution between diabetic and non-diabetic groups. Optical coherence tomography angiography (OCTA) will be performed preoperatively and at 1 month postoperatively to assess changes in choroidal vascularity. The primary objective is to determine whether the type of CPB flow affects choroidal microcirculation, particularly in diabetic patients. The findings may support more individualized perfusion strategies in patients at risk of ocular microvascular impairment.

Read the detailed description

This prospective observational study aims to investigate the effects of pulsatile and non-pulsatile cardiopulmonary bypass (CPB) flow types on choroidal and retinal microcirculation in diabetic and non-diabetic patients undergoing elective coronary artery bypass graft (CABG) surgery. Previous literature suggests that pulsatile perfusion may enhance end-organ perfusion, but data on ocular microvascular circulation remain scarce, especially in diabetic patients.

A total of 104 patients between the ages of 30 and 70 will be enrolled and divided into four groups based on diabetes status and CPB flow type. Optical coherence tomography angiography (OCTA) will be performed preoperatively and at 1 month postoperatively to measure the choroidal vascularity index (CVI) and other retinal microvascular parameters.The primary outcome is the change in CVI between baseline and 1-month follow-up. Secondary outcomes include retinal microvascular changes and comparative analyses between diabetic and non-diabetic groups.By evaluating the relationship between CPB flow type and ocular perfusion, particularly in patients with longstanding diabetes, this study may provide evidence to support individualized CPB strategies to minimize ocular microvascular compromise in cardiac surgery.

02

Conditions studied

  • Diabetic Retinopathy (DR)
  • Cardiopulmonary Bypass
  • Retinal Vascular Diseases

Browse trials for

Keywords

  • Diabetic Retinopathy
  • Cardiopulmonary Bypass
  • Pulsatile Flow
03

In context

Diabetic Retinopathy

772 studies on the registry are indexed under Diabetic Retinopathy; 138 are open to participants now.

This study's enrollment of 102 is below the median of 154 across 264 observational studies indexed under Diabetic Retinopathy.

Browse Diabetic Retinopathy studies →

Lead sponsor

Samsun University is the lead sponsor of 81 studies on the registry; 21 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
30 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients scheduled for elective coronary artery bypass grafting, including diabetic and non-diabetic individuals, recruited at a single center (Samsun Training and Research Hospital).

Inclusion criteria

  1. Age between 30 and 70 years
  2. Undergoing elective, first-time coronary artery bypass graft surgery (CABG)
  3. Stable metabolic status
  4. For diabetic group: history of diabetes mellitus for more than 10 years
  5. No significant ocular media opacity (e.g., cataract or vitreous hemorrhage)
  6. No tremor or condition interfering with OCTA imaging
  7. Aortic cross-clamp time ≤ 120 minutes

Exclusion criteria

Exclusion Criteria:

  1. Age \<30 or >70 years
  2. Re-do or emergency cardiac surgery
  3. Diabetes duration \<10 years (for diabetic group)
  4. Unstable metabolic state or active infection
  5. Presence of significant cataract, vitreous hemorrhage, or tremor
  6. Contraindications to OCTA imaging
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
102 participants (actual)
Patient registry
No

Groups and cohorts

  • Diabetic - Pulsatile Flow

    Diabetic patients undergoing elective coronary artery bypass grafting (CABG) with pulsatile cardiopulmonary bypass (CPB) flow. Preoperative and postoperative 1st month OCTA measurements will be taken.

  • Diabetic - Non-Pulsatile Flow

    Diabetic patients undergoing elective CABG with non-pulsatile CPB flow. OCTA measurements preoperatively and at 1 month postoperatively.

  • Non-Diabetic - Pulsatile Flow

    Non-diabetic patients undergoing elective CABG with pulsatile CPB flow. OCTA measurements preoperatively and at 1 month postoperatively.

  • Non-Diabetic - Non-Pulsatile Flow

    Non-diabetic patients undergoing elective CABG with non-pulsatile CPB flow. OCTA measurements preoperatively and at 1 month postoperatively.

06

What researchers measure

Primary outcomes

  1. Change in Choroidal Vascularity Index (CVI) from Baseline to 1-Month Postoperative

    CVI will be calculated from OCTA images preoperatively and 1 month postoperatively. Mean change in CVI will be compared between pulsatile and non-pulsatile CPB groups.

    Time frame: 1 month after surgery

Secondary outcomes

  1. Change in Retinal Vascular Density (RVD)

    RVD will be assessed by OCTA and measured as vessel density (%) at baseline and 1-month post-op, compared between study groups.

    Time frame: 1 month after surgery

  2. Change in Foveal Avascular Zone (FAZ) Area

    FAZ area will be measured preoperatively and 1 month postoperatively using OCTA, and compared across study groups.

    Time frame: 1 month after surgery

  3. Comparison of CVI Change Between Diabetic and Non-Diabetic Patients

    Subgroup analysis of CVI change will be performed to assess whether diabetes status affects choroidal perfusion response to CPB flow type.

    Time frame: 1 month after surgery

07

Study locations

1 site
  • Samsun University Faculty of Medicine
    Samsun, 55090, Turkey (Türkiye)
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 27, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07034612
Lead sponsor
Samsun University
Responsible party
Sponsor
First posted
Jun 24, 2025
Start date
Jan 1, 2023
Primary completion
Jan 1, 2025
Completion
Jan 1, 2025
Last update
Jun 27, 2025

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion